Johnson & Johnson is a global healthcare conglomerate engaged in the research, development, and manufacture of pharmaceuticals, medical devices, and consumer health products. With a mission to improve health for humanity, J&J operates across three segments: Innovative Medicine, focusing on areas like oncology and immunology; MedTech, providing surgical and orthopedic solutions; and Consumer Health, offering products in baby care, skin health, and oral care. The company emphasizes innovation, sustainability, and global health equity, delivering solutions that impact millions worldwide.
ETHICON's 3D Reloads and Gripping Surface Technology minimize tissue complexities and leaks/bleeds, with this advanced stapling exclusively for OTTAVA Robotic Surgical System.
The KINCISE 2 System enhances surgical control, expands hip/knee applications, and introduces Acetabular Cup Extraction, reducing fatigue and improving workflow versus manual methods.
Johnson & Johnson announces the FDA's committee vote supporting DARZALEX FASPRO to potentially delay or prevent progression in high-risk smoldering multiple myeloma.
The DUALTO electrosurgical generator is designed to offer a simplified user experience, access to Polyphonic Fleet digital device management, and flexible application of devices for open and minimally invasive surgery.
Building on last year’s momentum of 18 FDA 510(k) Clearances and 45 global product launches, the company accelerates innovation across joint reconstruction, trauma, spine, and more.
Highlights include the debut of the Solutions in Motion™ initiative aimed at bringing together advanced surgical techniques, innovative implants, and data-driven enabling technologies.
The dual-use robotics and standalone navigation platform will become part of the VELYS™ Enabling Technologies Portfolio and integrate with existing J&J MedTech Spine products.